Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization
The FASEB Journal · 2024
DOI: 10.1096/fj.202400446r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Theressa Ewa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Mesothelin, Pancreatic Neoplasms, GPI-Linked Proteins, Peritoneal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, HHS | NIH | National Cancer Institute (NCI), National Cancer Institute.
Abstract (Originalsprache)
Peritoneum is the second most common site of metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). Peritoneal colonization is impaired in PDAC cells with knockout (KO) of the cancer surface antigen mesothelin (MSLN) or by introducing Y318A mutation in MSLN to prevent binding to mucin‐16 (MUC‐16). MSLN has a membrane‐bound form but is also shed to release soluble MSLN (sMSLN). Their individual roles in peritoneal metastasis are unknown. Here, a C‐terminal truncated MSLN mutant (∆591) incapable of cell membrane insertion but proficient in secretion was engineered. Expression of ∆591 MSLN failed to rescue peritoneal metastasis in MSLN KO cells and inhibited peritoneal colonization when overexpressed in WT PDAC cells. Exposing PDAC cells to conditioned medium (CM) containing excess sMSLN impaired cancer cell clustering in vitro and in peritoneal fluid in vivo, while CM containing only Y318A sMSLN did not. These data demonstrate that interaction of membrane‐bound MSLN with MUC‐16 promotes cell clustering that is critical for efficient peritoneal metastasis. However, peritoneal colonization by MSLN KO cells was rescued by expression of ∆591 mutant MSLN bearing Y318A mutation, suggesting that sMSLN also has a MUC‐16‐independent role in peritoneal spread. Alterations in inflammatory signaling pathways occurred following KO cell exposure to CM containing sMSLN, and CM from cancer cells with intact peritoneal metastasis provoked increased KO cell secretion of IL‐1α. While excess sMSLN inhibits cell clustering and peritoneal colonization, sMSLN may also promote PDAC peritoneal metastasis independent of MUC‐16.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Theressa Ewa, Neel Panchwagh, Chin-Hsien Tai, Leela Rani Avula, Sarah Joseph, Michael W Rudloff, Nargis Malik, Xianyu Zhang, Christine Alewine
Förderung
- Intramural NIH HHS
- HHS | NIH | National Cancer Institute (NCI)
- National Cancer Institute
Zitieren
APA
Ewa, T., Panchwagh, N., Tai, C. H., Avula, L. R., Joseph, S., Rudloff, M. W., Malik, N., Zhang, X., & Alewine, C. (2024). Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization. The FASEB Journal. https://doi.org/10.1096/fj.202400446r
Vancouver
Ewa T, Panchwagh N, Tai CH, Avula LR, Joseph S, Rudloff MW, et al. Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization. The FASEB Journal. 2024. doi:10.1096/fj.202400446r
BibTeX
@article{Ewa2024,
author = {Ewa, Theressa and Panchwagh, Neel and Tai, Chin-Hsien and Avula, Leela Rani and Joseph, Sarah and Rudloff, Michael W and Malik, Nargis and Zhang, Xianyu and Alewine, Christine},
title = {Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202400446r}
}
EUVIMED